International Pharmaceutical Supply Chain Security Agreement Act of 2021
This bill establishes principal trade negotiating objectives of the United States with respect to pharmaceutical products, including objectives regarding subsidies and government procurement. It also extends through July 1, 2023 (or July 1, 2026, if the President receives an extension) the authority of the President to enter into trade agreements with foreign countries.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2021-07-27 | Committee | Referred to the Subcommittee on Trade. | House committee actions |
| 2021-07-27 | IntroReferral | Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2021-07-27 | IntroReferral | Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2021-07-27 | IntroReferral | Introduced in House | Library of Congress |